Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
2001 2
2002 1
2004 2
2005 1
2007 2
2008 5
2009 2
2010 1
2015 4
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
Medina D, Thompson H, Ganther H, Ip C. Medina D, et al. Nutr Cancer. 2001;40(1):12-7. doi: 10.1207/S15327914NC401_5. Nutr Cancer. 2001. PMID: 11799917 Review.
This review summarizes the rationale and results for use of a new organic selenium compound, Se-methylselenocysteine, which exhibits greater efficacy as a chemopreventive agent than several previously used selenium compounds in experimental models of breast cancer a …
This review summarizes the rationale and results for use of a new organic selenium compound, Se-methylselenocysteine, which exhibits …
Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo.
Fang MZ, Zhang X, Zarbl H. Fang MZ, et al. Cancer Prev Res (Phila). 2010 May;3(5):640-52. doi: 10.1158/1940-6207.CAPR-09-0170. Epub 2010 Apr 27. Cancer Prev Res (Phila). 2010. PMID: 20424134 Free PMC article.
Epidemiologic and animal studies indicate that disruption of circadian rhythm increases breast cancer risk. Previously, we showed that methylselenocysteine reduced the incidence of N-nitroso-N-methylurea (NMU)-induced mammary carcinomas in Fischer 344 rats by 63%. . …
Epidemiologic and animal studies indicate that disruption of circadian rhythm increases breast cancer risk. Previously, we showed tha …
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA, Burow ME, Rowan BG. Li Z, et al. Breast Cancer Res Treat. 2009 Nov;118(1):33-43. doi: 10.1007/s10549-008-0216-x. Epub 2008 Oct 15. Breast Cancer Res Treat. 2009. PMID: 18855134
To investigate the therapeutic effect of methylselenocysteine (MSC) combined with tamoxifen in MCF-7 breast cancer xenograft and the underlying mechanisms. MCF-7 breast cancer xenograft was established in ovariectomized female athymic nude mice and treated wi …
To investigate the therapeutic effect of methylselenocysteine (MSC) combined with tamoxifen in MCF-7 breast cancer xenograft a …
Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.
Johnson WD, Morrissey RL, Kapetanovic I, Crowell JA, McCormick DL. Johnson WD, et al. Food Chem Toxicol. 2008 Mar;46(3):1068-78. doi: 10.1016/j.fct.2007.11.001. Epub 2007 Nov 12. Food Chem Toxicol. 2008. PMID: 18082924 Free PMC article.
Se-methylselenocysteine (MSC) is an organoselenium compound being developed for breast cancer chemoprevention. ...
Se-methylselenocysteine (MSC) is an organoselenium compound being developed for breast cancer chemoprevention. ...
Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland.
Ip C, Dong Y. Ip C, et al. Anticancer Res. 2001 Mar-Apr;21(2A):863-7. Anticancer Res. 2001. PMID: 11396176
The results showed that the magnitude of the response to methylselenocysteine intervention seemed to depend on the size of the IDP lesion. ...Consistent with the induction of apoptosis, a reduced expression of bcl-2 was also observed in the methylselenocysteine grou …
The results showed that the magnitude of the response to methylselenocysteine intervention seemed to depend on the size of the IDP le …
[Effects of Se-methylselenocysteine on biological behavior of and matrix metalloproteinase-2 expression in human breast cancer MDA-MB-231 cells].
Wang J, Jiao NL, Zheng J. Wang J, et al. Ai Zheng. 2008 Feb;27(2):119-25. Ai Zheng. 2008. PMID: 18279606 Free article. Chinese.
BACKGROUND & OBJECTIVE: Se-methylselenocysteine (MSC), a natural organoselenium compound, has functions on chemoprevention and treatment of many tumors, but the mechanism remains unclear. ...CONCLUSIONS: MSC could inhibit proliferation, and induce apoptosis and S
BACKGROUND & OBJECTIVE: Se-methylselenocysteine (MSC), a natural organoselenium compound, has functions on chemoprevention and tr …
Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.
Zhang X, Zarbl H. Zhang X, et al. Cancer Prev Res (Phila). 2008 Jul;1(2):119-27. doi: 10.1158/1940-6207.CAPR-08-0036. Cancer Prev Res (Phila). 2008. PMID: 19122877 Free PMC article.
To identify signaling pathways involved in carcinogenesis that are also modulated by methylselenocysteine, we compared the global gene expression profiles in mammary tissues from pubescent female rats maintained on a selenium-supplemented (3 ppm) diet with those on a stand …
To identify signaling pathways involved in carcinogenesis that are also modulated by methylselenocysteine, we compared the global gen …
Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells.
Guo CH, Hsia S, Shih MY, Hsieh FC, Chen PC. Guo CH, et al. Int J Med Sci. 2015 Sep 5;12(9):748-58. doi: 10.7150/ijms.12177. eCollection 2015. Int J Med Sci. 2015. PMID: 26392813 Free PMC article.
The present study was aimed at evaluating the effects of Se yeast on oxidative stress, growth inhibition, and apoptosis in human breast cancer cells. Treatments of ER-positive MCF-7 and triple-negative MDA-MB-231 cells with Se yeast (100, 750, and 1500 ng Se/mL), methylsel …
The present study was aimed at evaluating the effects of Se yeast on oxidative stress, growth inhibition, and apoptosis in human breast
New concepts in selenium chemoprevention.
Ip C, Dong Y, Ganther HE. Ip C, et al. Cancer Metastasis Rev. 2002;21(3-4):281-9. doi: 10.1023/a:1021263027659. Cancer Metastasis Rev. 2002. PMID: 12549766 Review.
Studies with the rat mammary carcinogenesis model suggested that methylselenocysteine (MSC), a good precursor for generating methylselenol endogenously, is able to block clonal expansion of premalignant lesions in the mammary gland. ...These same cellular responses are rep …
Studies with the rat mammary carcinogenesis model suggested that methylselenocysteine (MSC), a good precursor for generating methylse …
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.
Unni E, Koul D, Yung WK, Sinha R. Unni E, et al. Breast Cancer Res. 2005;7(5):R699-707. doi: 10.1186/bcr1276. Epub 2005 Jul 6. Breast Cancer Res. 2005. PMID: 16168115 Free PMC article.
INTRODUCTION: Se-methylselenocysteine (MSC), a naturally occurring selenium compound, is a promising chemopreventive agent against in vivo and in vitro models of carcinogen-induced mouse and rat mammary tumorigenesis. We have demonstrated previously that MSC induces apopto …
INTRODUCTION: Se-methylselenocysteine (MSC), a naturally occurring selenium compound, is a promising chemopreventive agent against in …
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page